Addition of or switch to insulin therapy in people treated with glucagon-like peptide-1 receptor agonists: A real-world study in 66 583 patients

详细信息    查看全文

• 作者：Olga Montvida ; Kerenaftali Klein ; Sudhesh Kumar ; Kamlesh Khunti and Sanjoy K. Paul
• 刊名：Diabetes, Obesity and Metabolism
• 出版年：2017
• 出版时间：January 2017
• 年：2017
• 卷：19
• 期：1
• 页码：108-117
• 全文大小：1661K
• ISSN：1463-1326

文摘

Real world outcomes of addition or switch to insulin therapy in type 2 diabetes (T2DM) patients on glucagon-like paptide-1 receptor agonist (GLP-1RA) with inadequately controlled hyperglycaemia, are not known.